Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostacyclin does not affect insulin secretion in humans

C Patrono, F Pugliese, G Ciabattoni

    Prostaglandins
    |March 1, 1981
    PubMed
    Summary

    Prostacyclin (PGI2) infusion did not significantly alter insulin secretion or glucose tolerance in healthy individuals. This suggests PGI2 may not play a direct role in glucose metabolism, unlike PGE2.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps.

    Journal of thrombosis and haemostasis : JTH·2014
    Same author

    Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.

    European heart journal. Acute cardiovascular care·2014
    Same author

    Physiopathology of acute coronary syndromes.

    Platelets·2010
    Same author

    [Cellular mechanisms of regulation of the inflammatory response in atherosclerosis: the role of cell contact-mediated signaling].

    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·2009
    Same author

    High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment.

    Annals of the rheumatic diseases·2009
    Same author

    Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.

    Heart (British Cardiac Society)·2008

    Area of Science:

    • Endocrinology
    • Metabolic Research
    • Vascular Biology

    Background:

    • Prostacyclin (PGI2) is a potent vasodilator and inhibitor of platelet aggregation.
    • Previous research suggests prostaglandins, like PGE2, can influence insulin secretion and glucose metabolism.
    • The role of PGI2 in glucose homeostasis remains less understood.

    Purpose of the Study:

    • To investigate the effects of Prostacyclin (PGI2) infusion on insulin secretion.
    • To determine the impact of PGI2 on glucose tolerance in healthy subjects.
    • To compare the metabolic effects of PGI2 with those of PGE2.

    Main Methods:

    • Infusion of Prostacyclin (PGI2) in healthy volunteers at varying doses (2.5-20 ng/Kg/min).
    • Administration of an intravenous glucose pulse (20 g) to assess acute insulin response.

    Related Experiment Videos

  • Measurement of glucose and insulin concentrations before and during PGI2 infusion.
  • Calculation of glucose disappearance rates.
  • Main Results:

    • PGI2 infusion did not cause statistically significant changes in glucose or insulin concentrations.
    • Acute insulin responses to glucose pulses were not inhibited by PGI2.
    • Glucose disappearance rates remained similar with and without PGI2.
    • PGI2 did not affect insulin secretion or glucose disposal at doses affecting platelets and vasculature.

    Conclusions:

    • Prostacyclin (PGI2) does not appear to directly influence insulin secretion or glucose disposal in healthy individuals.
    • Unlike PGE2, PGI2 does not exhibit significant metabolic effects at pharmacologically relevant doses.
    • An imbalance in the PGI2/PGE2 ratio in diabetes may link vascular, platelet, and metabolic dysfunctions.